Literature DB >> 2826532

Comparison of five assays for antibody to varicella-zoster virus and the fluorescent-antibody-to-membrane-antigen test.

P Larussa1, S Steinberg, E Waithe, B Hanna, R Holzman.   

Abstract

Three commercially available assays (the Varicelisa Test Kit [Whittaker M.A. Bioproducts, Walkersville, Md.], the VZV Indirect Fluorescent-Antibody Test [Electro-Nucleonics, Inc., Columbia, Md.], and the Litton VZV Bio-EnzaBead Screen Kit [Litton Bionetics, Inc., Charleston, S.C.]) and two enzyme-linked immunosorbent assays used in our laboratory, one using a membrane-associated antigen and the other using a soluble antigen dotted on nitrocellulose paper, were compared with a varicella-zoster virus antibody reference assay, the fluorescent-antibody-to-membrane-antigen test. All of the assays compared favorably to the fluorescent-antibody-to-membrane-antigen test when evaluated for sensitivity (0.95), specificity (0.84), and test-retest reliability (79 to 96%), except for the Litton assay, which demonstrated significantly different results for all of the parameters tested (0.55, 1.0, and 69%, respectively).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2826532      PMCID: PMC269411          DOI: 10.1128/jcm.25.11.2059-2062.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells.

Authors:  J A Zaia; M N Oxman
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

2.  Diagnostic skin test reactions with varicella virus antigen and clinical application of the test.

Authors:  H Kamiya; T Ihara; A Hattori; T Iwasa; M Sakurai; T Izawa; A Yamada; M Takahashi
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

3.  Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence.

Authors:  V Williams; A Gershon; P A Brunell
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

4.  Measurement of antibodies to varicella-zoster virus in a tropical population by enzyme-linked immunosorbent assay.

Authors:  A R Venkitaraman; J M Seigneurin; M Baccard; G M Lenoir; T J John
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

5.  Varicella zoster in hospital personnel: skin test reactivity to monitor susceptibility.

Authors:  R W Steele; M A Coleman; M Fiser; R W Bradsher
Journal:  Pediatrics       Date:  1982-10       Impact factor: 7.124

6.  Hospital experience with varicella-zoster virus.

Authors:  K Krasinski; R S Holzman; R LaCouture; A Florman
Journal:  Infect Control       Date:  1986-06

7.  Hospital infection control for varicella zoster virus infection.

Authors:  M G Myers; D A Rasley; W J Hierholzer
Journal:  Pediatrics       Date:  1982-08       Impact factor: 7.124

8.  Susceptibility to varicella virus of certain adults in the southeastern United States.

Authors:  P J Hyams; S Vernon; D Eckert
Journal:  Am J Infect Control       Date:  1984-02       Impact factor: 2.918

9.  Clinical reinfection with varicella-zoster virus.

Authors:  A A Gershon; S P Steinberg; L Gelb
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

10.  Antibody to Varicella-Zoster virus in parturient women and their offspring during the first year of life.

Authors:  A A Gershon; R Raker; S Steinberg; B Topf-Olstein; L M Drusin
Journal:  Pediatrics       Date:  1976-11       Impact factor: 7.124

View more
  11 in total

1.  The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits.

Authors:  J P Struewing; K C Hyams; J E Tueller; G C Gray
Journal:  Am J Public Health       Date:  1993-12       Impact factor: 9.308

2.  Comparison of two methods for detecting varicella-zoster virus antibody with varicella-zoster virus cell-mediated immunity.

Authors:  A Weinberg; A R Hayward; H B Masters; I A Ogu; M J Levin
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

3.  Effect of varicella-zoster virus (VZV) fluorescent-antibody-to-membrane-antigen (FAMA) testing on sensitivity of determining VZV immunity in healthcare workers and on furlough days.

Authors:  Lori Rolando; William J Schneider; Sharon Steinberg; Sulin Low; Jeffrey Stiles; Luz Gomez; Anne A Gershon; Arthur E Brown
Journal:  Infect Control Hosp Epidemiol       Date:  2010-09       Impact factor: 3.254

Review 4.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

5.  Primary vaccine failure after 1 dose of varicella vaccine in healthy children.

Authors:  David E Michalik; Sharon P Steinberg; Philip S Larussa; Kathryn M Edwards; Peter F Wright; Ann M Arvin; Haley A Gans; Anne A Gershon
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

6.  Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay.

Authors:  P A C Maple; J Gray; J Breuer; G Kafatos; S Parker; D Brown
Journal:  Clin Vaccine Immunol       Date:  2006-02

7.  Seroepidemiology of varicella-zoster virus in Korean adolescents and adults using fluorescent antibody to membrane antigen test.

Authors:  S B Han; K R Kang; D H Huh; H C Lee; J H Kim; J H Kang; S H Ma
Journal:  Epidemiol Infect       Date:  2014-09-19       Impact factor: 2.451

8.  Negative IgG Varicella Zoster Virus Antibody Status: Immune Responses Pre and Post Re-immunization.

Authors:  Tamar A Smith-Norowitz; Tehila A Saadia; Kevin B Norowitz; Rauno Joks; Helen G Durkin; Stephan Kohlhoff
Journal:  Infect Dis Ther       Date:  2017-12-22

9.  Epidemiology of Breakthrough Varicella after the Implementation of a Universal Varicella Vaccination Program in Taiwan, 2004-2014.

Authors:  Hao-Yuan Cheng; Luan-Yin Chang; Chun-Yi Lu; Li-Min Huang
Journal:  Sci Rep       Date:  2018-11-21       Impact factor: 4.379

10.  Strategies for prevention of varicella pneumonia: a cost-effectiveness analysis.

Authors:  G A Macones; S Ewing; N S Silverman
Journal:  Infect Dis Obstet Gynecol       Date:  1996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.